These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 24769729)
1. ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7. Lu Z; Yang H; Sutton MN; Yang M; Clarke CH; Liao WS; Bast RC Cell Death Differ; 2014 Aug; 21(8):1275-89. PubMed ID: 24769729 [TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. Lu Z; Luo RZ; Lu Y; Zhang X; Yu Q; Khare S; Kondo S; Kondo Y; Yu Y; Mills GB; Liao WS; Bast RC J Clin Invest; 2008 Dec; 118(12):3917-29. PubMed ID: 19033662 [TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts. Mao W; Peters HL; Sutton MN; Orozco AF; Pang L; Yang H; Lu Z; Bast RC Cancer; 2019 Apr; 125(8):1267-1280. PubMed ID: 30620384 [TBL] [Abstract][Full Text] [Related]
4. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts. Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722 [TBL] [Abstract][Full Text] [Related]
5. The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Badgwell DB; Lu Z; Le K; Gao F; Yang M; Suh GK; Bao JJ; Das P; Andreeff M; Chen W; Yu Y; Ahmed AA; S-L Liao W; Bast RC Oncogene; 2012 Jan; 31(1):68-79. PubMed ID: 21643014 [TBL] [Abstract][Full Text] [Related]
6. RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Sutton MN; Yang H; Huang GY; Fu C; Pontikos M; Wang Y; Mao W; Pang L; Yang M; Liu J; Parker-Thornburg J; Lu Z; Bast RC Autophagy; 2018; 14(4):637-653. PubMed ID: 29368982 [TBL] [Abstract][Full Text] [Related]
7. ARHI overexpression induces epithelial ovarian cancer cell apoptosis and excessive autophagy. Li J; Cui G; Sun L; Wang SJ; Tian S; Guan Z; Fan WS; Yan ZF; Yang YZ; You YQ; Fu XY; Li LA; Huang K; Li YL; Meng YG Int J Gynecol Cancer; 2014 Mar; 24(3):437-43. PubMed ID: 24476894 [TBL] [Abstract][Full Text] [Related]
8. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. Zou CF; Jia L; Jin H; Yao M; Zhao N; Huan J; Lu Z; Bast RC; Feng Y; Yu Y BMC Cancer; 2011 Jan; 11():22. PubMed ID: 21244707 [TBL] [Abstract][Full Text] [Related]
9. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345 [TBL] [Abstract][Full Text] [Related]
10. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration. Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514 [TBL] [Abstract][Full Text] [Related]
11. Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models. Ornelas A; McCullough CR; Lu Z; Zacharias NM; Kelderhouse LE; Gray J; Yang H; Engel BJ; Wang Y; Mao W; Sutton MN; Bhattacharya PK; Bast RC; Millward SW BMC Cancer; 2016 Oct; 16(1):824. PubMed ID: 27784287 [TBL] [Abstract][Full Text] [Related]
12. DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells. Lu Z; Baquero MT; Yang H; Yang M; Reger AS; Kim C; Levine DA; Clarke CH; Liao WS; Bast RC Autophagy; 2014 Jun; 10(6):1071-92. PubMed ID: 24879154 [TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Lu Z; Bast RC Cell Adh Migr; 2013; 7(2):232-6. PubMed ID: 23357870 [TBL] [Abstract][Full Text] [Related]
14. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma. Zhong C; Shu M; Ye J; Wang X; Chen X; Liu Z; Zhao W; Zhao B; Zheng Z; Yin Z; Gao M; Zhao H; Wang K; Zhao S BMC Cancer; 2019 May; 19(1):441. PubMed ID: 31088402 [TBL] [Abstract][Full Text] [Related]
16. ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. Huang S; Chang IS; Lin W; Ye W; Luo RZ; Lu Z; Lu Y; Zhang K; Liao WS; Tao T; Bast RC; Chen X; Yu Y Biosci Rep; 2009 Dec; 30(3):159-68. PubMed ID: 19435463 [TBL] [Abstract][Full Text] [Related]
17. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture. Ye K; Wang S; Yang Y; Kang X; Wang J; Han H Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148 [TBL] [Abstract][Full Text] [Related]
19. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells. Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]